COVID-19: DCGI gives nod to anti-COVID drug developed by DRDO

The Drugs Controller General of India approved the drug 2-deoxy-D-glucose (2-DG) which is developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), DRDO in collaboration with Dr. Reddy’s Lab.